A biomedical research program based at the University of Rhode Island has received $18.8 million in new grant funding from the National Institutes of Health.
Created in 2001, The Rhode Island IDeA Network of Biomedical Research Excellence (RI-INBRE), was intended to expand the state's biomedical research capacity. Since that time, it has received $42 million in federal grants, according to URI officials.
The new funding will shift the focus to research in areas of cancer, neuroscience and molecular toxicology.
The Miriam Hospital has received another multimillion dollar grant from the National Institutes of Health to support HIV and AIDS research. The money will fund research into new treatments.
The Miriam is the state’s largest provider of HIV and AIDS care. The grant of $2.4 million dollars is a renewal that will help the institution continue its work as part of a multi-site aids research consortium, called the AIDS Clinical Trials Group (ACTG) Network. That group’s work helped pioneer a new way to keep pregnant mothers from transmitting HIV to their babies.
Lifespan Hospital system’s growing research complex in Providence’s Jewelry District will benefit from a large National Institutes of Health grant to open new labs and fund new projects. Some of that research could translate into new treatments for Rhode Island patients.